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Abstract
Background: NHS Stop Smoking Services in the UK provide cost effective smoking cessation
interventions, but approximately 75% of smokers who are abstinent at 4 weeks relapse to smoking
by 12 months. This study aimed to explore health professionals' understanding of relapse
prevention interventions (RPIs), the feasibility of offering such support and whether and how these
are currently used in UK NHS Stop Smoking Services.
Methods: Sixteen health professionals working in UK NHS Stop Smoking Services, selected from
those attending a national conference were interviewed and Framework Analysis was used to
identify recurrent key themes and concepts in their perceptions and experiences of providing
relapse prevention interventions (RPIs).
Results: Interviewees had diverse perceptions of relapse prevention as a concept. Whilst relapse
prevention was largely seen as support to prevent abstinent smokers from relapsing to smoking,
some interviewees stated that RPIs were being delivered to lapsed or relapsed smokers. Current
provision of RPIs was most commonly described as behavioural counselling being offered
predominantly after completed cessation treatment, often in the format of 'rolling groups' which
the client was encouraged to attend. Commonly identified barriers to the introduction of RPIs
were funding and government targets focussed on short term cessation, smokers' low uptake of
offered RPIs and an uncertain evidence base for their effectiveness. Interviewees were positive
about the potential use of pharmacotherapy for relapse prevention, but were negative about the
possibility of introducing proactive telephone counselling for this purpose.
Conclusion: There is currently no shared understanding of the concept of relapse prevention
amongst this sample of health professionals working in UK NHS Stop Smoking Services. For RPIs
to be systematically delivered via these services, a commonly-held, widely-accepted and
understood definition of relapse prevention would be needed. Other barriers towards introducing
RPIs, such as their weak evidence and the short term cessation-focussed targets against which UK
stop smoking services are measured, would also need addressing and interventions which are
acceptable to abstinent smokers would need to be developed.
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Background
NHS Stop Smoking Services were established from 1999
onwards across the UK to provide support for motivated
smokers who wish to quit. The effectiveness of these serv-
ices has been demonstrated: for example, more than half
of English services' clients achieve validated abstinence
from smoking for at least four weeks and around 15% do
so for at least a year[1]. Services are also very cost-effective,
achieving an average cost per life year saved, after allow-
ance for future health care savings, of £438 [2], which is
over 50 times below the English National Institute of
Health and Clinical Excellence's benchmark cost-effective-
ness figure of £30,000 [3]. Services' clients are offered
pharmacotherapy and behavioural therapy in group or
individual settings [4], but as the figures above suggest,
quitters' rates of relapse to smoking are high, with around
75% of those abstinent at 4 weeks after their quit date re-
starting smoking by one year [1].
If stop smoking services provided abstinent smokers who
are making quit attempts with effective treatments to
reduce their rates of relapse to smoking (relapse preven-
tion interventions, RPIs), then long term prolonged cessa-
tion rates could, potentially, be greatly improved.
However, the evidence base for using RPIs is weak; a 2006
Cochrane review of pharmacotherapy, extended treat-
ment interventions and interventions designed to provide
smokers with skills to avoid relapse to smoking, found no
evidence that any of these approaches worked for relapse
prevention, although the evidence base was small [5]. As
part of an investigation into the feasibility and potential
effectiveness of introducing RPIs into the NHS, this evi-
dence base is being updated and attitudes to the potential
use of RPIs are being investigated. We report here the find-
ings of a qualitative study which investigated the views,
knowledge and understanding concerning RPIs of health
professionals working in UK NHS Stop Smoking Services
and also their experiences of providing RPIs in clinical
practice. Factors which could hinder or encourage the effi-
cient provision of RPIs in UK NHS Stop Smoking Services
were also investigated.
Methods
Design
Health professionals working in UK Stop Smoking Serv-
ices attending a UK smoking cessation conference in 2007
were asked to indicate their willingness to be interviewed
at a later date on relapse prevention and 23 professionals
provided contact details. All 23 were emailed seven
months after the conference, invited to re-confirm their
willingness to take part and agree a convenient time to be
interviewed. Non-respondents to the email were con-
tacted via telephone two weeks later. A literature review
identified issues of potential importance to RPIs and,
using these, a semi-structured interview schedule, with
prompts (Appendix 1) was developed. Throughout inter-
views, open-ended questions were used to encourage par-
ticipants to answer freely and these were conducted by SA
via telephone in January and February 2008. Interviews
covered the following subjects: knowledge and under-
standing of relapse prevention, types and duration of RPI
provided and barriers and challenges encountered. Each
interview lasted 20–25 minutes and all were audio-taped
and transcribed verbatim.
Analysis
Table 1 summarises the process of data analysis. The inter-
views were analysed using the Framework Method [6].
The first stage of analysis involved identifying initial
themes or concepts. The themes and categories on which
the analysis is based were derived from the data, rather
than being imposed by the researchers [7]. The definition
of emergent themes and categories were checked against
the data, and subsequently refined in an iterative process
[8]. Themes and sub-themes were given unique codes and
a manageable index was constructed. The index was sub-
sequently applied to the raw data, and the references were
noted in the margins of the transcripts. The next stage
Table 1: Process of data analysis
SA reads all transcripts in an iterative process to identify themes and sub-themes 
(variations in advisor experiences of providing relapse prevention treatments and variations in thinking within themes)
SA designs a framework (index) with themes and sub-themes and their working definitions
TC and AMc agree working definitions for the emerging themes and sub-themes
SA codes the transcripts for the themes. Data relating to each theme is assembled. TC and AMc independently read 10 randomly selected 
transcripts to see if they are being coded consistently
Working definitions for themes and sub-themes are refined. The framework (index) is re-structured to reflect the changes
SA re-codes the transcripts using the refined definitions.
TC and AMc check reliability of the data and interpretation of the findings at each stage of the processBMC Health Services Research 2009, 9:67 http://www.biomedcentral.com/1472-6963/9/67
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involved constructing charts with rows and columns for
each of the main themes and sub-themes that emerged.
This process of "charting" allows allocation of the main
themes to each column on the chart, and each interview
transcript is assigned to a particular row. It ensures that
enough data and context are included in the charts such
that the analyst is not required to go back to the tran-
scribed data to understand the point being made [6]. Each
interview stays in the same location on every chart. After
charting all the interviews, interview text relating to the
research aims and objectives was collated from the themes
and sub-themes. Finally, AMc and TC read a sample of ten
randomly selected transcripts and confirmed that the tran-
scripts were coded consistently and they contained data
that supported the key findings of the study. Any disagree-
ments were resolved by discussion.
Results
Response
Of the 23 individuals who had indicated their willingness
to participate in the study, four could not be contacted
and three potential participants indicated that they no
longer wished to participate, so a total of 16 interviews
were conducted (12 with females). Fifteen interviewees
were smoking cessation professionals who were also
responsible for overseeing the day-to-day activities of their
respective services or actively involved in managing one
aspect of the service in which they worked and one was a
regional tobacco control lead. We report our interpreta-
tion of health professionals' accounts below. Quotes from
interviewees appear in Tables Three to Five and they are
attributable to individual interviewees by code numbers.
The themes
Three broad themes emerged from interview data: beliefs,
knowledge and understanding of relapse prevention; RPIs
for abstinent/lapsed and relapsed smokers; and, barriers
and challenges. A summary of the themes and sub-themes
is shown in Table 2.
Beliefs, knowledge and understanding of relapse 
prevention
Interviewees had diverse perceptions of relapse preven-
tion as a concept and shared no common definition of
what this should entail (see Table 3). Their definitions of
relapse prevention mostly appeared to be informed by the
ways in which the cessation services for which they
worked currently attempted to help abstinent smokers to
remain stopped and achieve long term abstinence. Inter-
viewees believed that relapse prevention should be
mainly provided for abstinent smokers to help them
remain smoke-free and prevent lapses by extending their
acute treatment Some health professionals also believed
that RPIs could be used for the treatment of lapsed (i.e.
people who had smoked one or two cigarettes) or
relapsed smokers (i.e. people who were now smoking
regularly again).
Prevention of lapses
Most participants understood/thought that relapse pre-
vention involved preventing lapses by providing treat-
ment for longer than a 'usual' seven to eight week period,
believing that, irrespective of the type of intervention
used, offering acute cessation treatment for longer periods
would ensure that more smokers remained abstinent.
Table 2: Index of themes and sub-themes
Beliefs, knowledge and understanding of relapse prevention
Prevention of lapses
Treatment of lapses
Treatment of relapsed smokers
Relapse prevention support for abstinent/lapsed and relapsed smokers
Support for abstinent/lapsed smokers
Content
Behavioural counselling & pharmacotherapy
Telephone follow up
Social Activities
Uptake
Support for relapsed smokers
Content
Rolling groups
Recycling – fresh quit attempt
Uptake
Barriers and challenges
Funding
Government targets
Paucity of information about effective relapse prevention interventionsBMC Health Services Research 2009, 9:67 http://www.biomedcentral.com/1472-6963/9/67
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Almost all participants stated that relapse to smoking was
most frequent when smokers ran out of medication,
which perhaps explains the strong belief that extending
treatment would prevent lapses. The treatment was often
either group or individual behavioural support, and was
extended beyond the usual timeframe for which acute ces-
sation treatment is provided.
Treatment of lapses
A small number of interviewees described relapse preven-
tion as providing support for smokers who have already
had a minor 'lapse' (i.e. smoked a few cigarettes during an
otherwise abstinent period) to prevent subsequent com-
plete relapse. Interviewees believed that a single lapse
could be sufficient to precipitate a later, complete relapse
and that managing these would substantially reduce the
risk of smokers returning to regular smoking. Interview-
ees, again, provided a content-centred definition for
relapse prevention as being the treatment of lapses citing
the provision of behavioural support and pharmacother-
apy as potentially effective for those who had smoked a
few cigarettes during an otherwise abstinent period.
Treatment of relapsed smokers
Interviewees also described relapse prevention as provid-
ing treatment for smokers who have fully relapsed to
smoking. They define this, again, in terms of the content
of the relapse prevention intervention and reveal that this
usually involved encouraging the client to begin a fresh
quit attempt and begin acute cessation treatment again or
attendance at 'rolling groups' (defined below).
Relapse prevention interventions for abstinent/lapsed and 
relapsed smokers
Interviewees described RPIs for abstinent/lapsed and
relapsed smokers in terms of the types of support which
could be provided and these differed for the two groups
(see Table 4). They also reflect on the uptake of such sup-
port when offered within their services.
Support for abstinent/lapsed smokers
Content
Behavioural counselling & pharmacotherapy
Interviewees revealed that behavioural counselling was
one of the most favoured forms of treatment used to help
smokers who have quit or who have had one or two brief
lapses remain smoke-free. The treatment is usually pro-
vided on an individual or group basis and these smokers
are helped to identify situations and triggers that might
lead to smoking lapses or relapse, taught strategies to help
overcome the associated urge for a cigarette, and steps to
take to prevent lapses, and the case of those who have had
one or two lapses, steps to prevent full blown relapse.
They are also helped to understand that relapse is a spon-
taneous, unplanned thought process or phenomenon
which is often triggered by external factors such as holi-
days, bereavement, and unexpected personal or financial
difficulties, and are equipped with strategies to deal with
these. Few individuals spontaneously mentioned the use
of pharmacotherapy to prevent relapse but all were asked
to comment on the feasibility of using pharmacotherapies
for relapse prevention (given emerging evidence on its
effectiveness, see below) and most interviewees were pos-
itive about this. (Table 4).
Telephone follow up
Some interviewees reported that their services provide tel-
ephone follow up calls or text messaging to support absti-
nent clients who had completed acute cessation
treatment. Advisors kept in touch with abstinent smokers
via telephone to provide motivation and support, when
needed, and to help them remain smoke-free with rela-
tively short calls (< 10 minutes) made at times specified
by clients as convenient. During the call, the advisor reit-
Table 3: Beliefs, knowledge and understanding of relapse prevention
Prevention of lapses
"Relapse prevention is making sure that, to try and stop people lapsing back to smoking, that's what I understand relapse prevention would mean".
"It is some action, some clinical action that the practitioner takes in order to prevent the patient from in the first place lapsing that automatically implies that it 
would help prevent relapse". 12
"Relapse prevention to me is, we have an open clinic, we see them initially for at least seven weeks, but it doesn't finish at either at six or seven weeks, they can 
come for as long as they like". 13
Treatment of lapses
"Well it's for people who have tried to stop smoking and have lapsed, and they don't want to go back through the whole system again, they just need something 
to get them back on track again," 10
"I've always felt that it's enabling clients to remain quit in the long term.......so that at the point where they've had one lapse, they actually get support to prevent 
them from turning into one great big relapse". 2.
Treatment of relapsed smokers
"It's really about people who have relapsed to smoking, regularly, and have gone into full-blown relapse, where they are now smoking regularly, and they need 
help to actually stop". 1BMC Health Services Research 2009, 9:67 http://www.biomedcentral.com/1472-6963/9/67
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erated the advantages of remaining smoke-free and
reminded clients to contact the service once he/she expe-
riences the urge to smoke a cigarette. Interviewees were
quick, however, to point out that proactive telephone
counselling for relapse prevention was logistically diffi-
cult and, as many clients found the calls intrusive, not a
favoured intervention. They believed calls could be an
unwelcome reminder for smokers that abstinence could
be difficult to maintain (Table 4).
Social Activities
Interviewees talked about using 'diversion therapy' as a
relapse prevention intervention for abstinent smokers.
This was often reported to involve engaging clients in
activities designed to take their minds off smoking, and
provide them with feelings of well-being and importance,
Activities were specially organised and could be con-
ducted by the smoking cessation service or in community
or leisure centres. Regular group activities could be lead by
an abstinent smoker and those described included bak-
ing/cooking, community services and visiting hospices or
nursing homes to lend support to residents.
Uptake
Interviewees revealed that where RPIs had been offered,
most clients did not take advantage of them and it was dif-
ficult to keep providing them. They admit that an impor-
tant focus in the management of smoking relapse should
Table 4: Relapse prevention interventions for abstinent/lapsed and relapsed smokers
Support for abstinent/lapsed smokers
Content
Behavioural counselling & pharmacotherapy
"We run a group, so they can come in for a series of sessions which cover general healthy lifestyle, like healthy eating, getting advice, and stress reduction". 6.
"Well everything that is involved in behavioural support, going through every situation they may encounter, preparing themselves for that, looking at tactics to 
cope with situations....if they've got anything in particular they're worried about, we will approach it in a practical but relaxed manner". 2
"We work with people, whatever their issues/triggers are, we would deal with, it doesn't matter what it is, if its debt management, crisis resolution, if in quitting 
smoking they've got problems that need dealing with, we would deal with it". 5
"I would strongly recommend that (pharmacotherapy) because as I said, a lot of patients reported that they actually relapsed right after they are not provided 
with medications". 3
"I think it (pharmacotherapy) would be fantastic".5
Telephone follow up
"We do telephone follow-ups, say between six and twelve months, just to ask them how they are getting on, and to let them know they can access the service 
again and again, at any point they need". 18
"The problem you have there is if you are going to phone everybody, you have to have the manpower, the resources to do that, from a resource point of view, I 
wouldn't have time to phone everybody at the moment". 13
"It would be very hard for us to that, to phone everyone up would be ideal but impossible at the moment".15
Social activities
"We do use interventions such as diversion therapy, by getting people into community groups and community support....we don't send them home to continue 
sorting out themselves, we get them out in the community, get them busy and get them involved in things, they need to be busy and out there and feeling 
useful... we get them to go to care homes and just you know, do peoples' hair and make them cups of tea, its just engaging them with whatever involves them". 
5
Uptake
"I think the picture is actually, people poorly attend relapse prevention. Because they feel once they've actually reached the quit, they don't need any help...a lot 
of smokers don't want you chasing them up, a lot of them are fed up if you do contact them". 6
"We used to, a couple of times a year, we'd put on like an open session, and invite everybody who'd been to the group in the last year, we'd put on a bit of food 
and make it a social event, and do some stuff about staying quit, but very few people attended, so it tended to be a waste of our time, so we didn't continue it". 
16
Support for relapsed smokers
Content
Rolling groups
"We don't have any formal relapse groups, but there are no barriers to re-entry of the service, for example in my 12 week group, drop-in group, people can 
come along who have relapsed and re-join the group again". 12
"We have a rolling group that is open for anybody who wants to come back in at any time". 14
Recycling
"Yes, it's a new quit attempt isn't it? (For relapsed smokers). You would go over the reasons for relapse and then you need to go through the whole process of 
another quit attempt". 16
Uptake
"A lot of people would rather, even though you've built up a rapport, struggle than bother you, so they think, oh no, I've failed now, they may have had one, two 
cigarettes, they don't contact you, so that tends to be a problem.". 8
"I think, when you, from my experience as an ex-smoker, if you're trying to give up, and you've slipped up, and then somebody is ringing you, you think Oh God 
no, it's that woman again, and feel really bad". 13
"The trouble is when people do relapse there's sort of, they're embarrassed to come back". 15BMC Health Services Research 2009, 9:67 http://www.biomedcentral.com/1472-6963/9/67
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be to help the smoker overcome such emotions. Inter-
viewees' accounts suggest that making the client aware
early on in the quit attempt of the possibility of relapse
further down the quitting process may prepare the smoker
for relapse and diminish the feelings of disappointment
they may suffer.
Support for relapsed smokers
Content
Rolling groups
In some services, smokers who had already been treated
but had relapsed to smoking were able to access 'rolling
groups'. Health professionals described this as an 'open
door' policy, with relapsed clients always free to return to
the service and re-join support groups. 'Rolling groups'
would not have fixed start or completion dates, so clients
wishing to re-enter the service for help would be able to
do so. Groups were perceived as able to provide clients the
opportunity to mix with individuals who had received
acute cessation treatment, relapsed, but had been able to
become abstinent again. The groups are often led by a
trained advisor and the sessions focus on, in addition to
other issues, helping the smokers deal with circumstances
that might lead to relapse.
Recycling – fresh quit attempt
In other services smokers who have suffered a full blown
relapse were encouraged to re-enter the service as a fresh
quit case. According to these health professionals'
accounts, once a person has fully relapsed to smoking,
relapse prevention is no longer appropriate and the indi-
vidual is classified as a fresh quit attempt and begins the
process of quitting smoking all over again.
Uptake
This process of re-cycling is often hampered by the unwill-
ingness of the smoker to admit to relapse. Health profes-
sionals' accounts suggest that providing RPIs was made
difficult by service users' profound feelings of failure and
embarrassment after relapsing, plus reluctance to admit to
relapse. Clients generally accessed services for cessation
treatments and they might not view Stop Smoking Serv-
ices as an appropriate place to seek help with lapses and
brief relapses.
Barriers and challenges to using relapse prevention 
interventions
Funding and pressure to meet Government targets which
are focussed on short term cessation and paucity of infor-
mation as to the most effective relapse prevention inter-
ventions were repeatedly identified as challenges to the
provision of RPIs (see Table 5).
Funding
Nearly all health professionals stated that drug budgets
and funding constituted major obstacles to the introduc-
tion of RPIs for smokers. A number of interviewees
revealed that they stopped providing RPIs due to a lack of
funds for additional support beyond that provided during
cessation treatment. Interviewees were positive about pro-
viding these interventions for motivated smokers if health
authorities allocated adequate funding.
Government targets focussed on short term cessation
Interviewees' accounts suggested that the need to meet
Government targets for NHS Stop Smoking Services exerts
considerable pressure on them. Even for health profes-
sionals who were interested in and willing to provide
RPIs, the pressure to achieve short term cessation for
smokers (i.e. 4 week quits) often reduced the amount of
time and resources that could be devoted to RPIs. Inter-
viewees recognize this conflict and repeatedly identified
this as a noteworthy barrier to the provision of RPIs
within their services.
Table 5: Quotes relating to barriers and challenges
Funding
"We used to have a relapse prevention session, wherein we invite everyone that came to our service to attend these clinics, but we don't do that anymore 
because of financial pressures". 3
"I think most PCTs would be prepared to pay for a course of treatment, but not an extended course of treatment, that's why they cut down to stop methods 
unlikely to be funded locally". 4
Government targets
"If you've got very busy clinics and you have Department of Health Targets to meet, you know, there's always a bit of a squeeze, in terms of how much time 
you've got for people to see you beyond their successful four week quit". 7
"I think you know, the fact that we are so target driven, and the fact that reporting successes is at a month rather than if it was three months or something like 
that, you know the whole drive would be to see patients longer......although I think targets are probably a good thing overall, because it does focus you on hitting 
the three pots and all the rest of it, but I think it can be a bit counter- productive". 14
Paucity of Information about effectiveness of RPIs
"I don't think we've got anything in black and white, to be honest". 1BMC Health Services Research 2009, 9:67 http://www.biomedcentral.com/1472-6963/9/67
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Paucity of information about effective relapse prevention 
interventions
A lack of available evidence on the effectiveness of RPIs
was perceived as a barrier to their use by some partici-
pants. It was believed that it would be easier to provide
these interventions for motivated smokers if there was
readily available and accessible information in the litera-
ture as to the most effective RPIs. Many indicated that they
would be able to integrate RPIs into their mainstream
service, but only if there was sufficient evidence regarding
the effectiveness of these interventions.
Discussion
Summary of findings
This sample of health professionals working in UK NHS
Stop Smoking Services do not appear to have a shared
understanding of what interventions aimed at preventing
relapse to smoking should encompass. Interviewees' used
their experiences to conceptualise relapse prevention and
their beliefs and understanding of this were often based
on the kinds of support that services in which they worked
offered as relapse prevention to clients. Interviewees
believed that introducing relapse prevention support into
NHS Stop Smoking Services would be hindered by current
performance targets which are focussed on achieving
short term abstinence from smoking, following cessation
treatment. There had been low uptake of RPIs in services
which previously offered this and interviewees were nega-
tive about introducing additional, proactive telephone
support counselling as an RPI, but were much more posi-
tive about the possibility of using pharmacotherapy for
this purpose.
Important emergent issues
Interviewees were generally positive about the potential
for using RPIs for smokers accessing stop smoking serv-
ices, but their varied descriptions of interventions indi-
cated that they did not share a common definition of what
these interventions should involve. Some believed relapse
prevention should be aimed at lapsed smokers but, more
commonly, it was perceived appropriate for preventing
relapse among smokers who were still abstinent and
attempting to quit. Often no distinction was made
between relapse prevention treatments and routine cessa-
tion treatment. It is, perhaps, unsurprising to find differ-
ences of opinion about RPIs amongst health
professionals, because the scientific literature on the sub-
ject describes studies which appear to conceptualise
relapse prevention in different ways too. A Cochrane
review described relapse prevention interventions as those
which explicitly seek to reduce relapse rates after an acute
treatment phase is successfully completed, or at some
time after the date of the quit attempt [5]. However, stud-
ies in this review and which satisfied this definition
include some which randomised abstainers and provided
behavioural treatments [9,10] and/or drug treatments
used for extended periods [11,12] and studies which ran-
domised smokers and provided behavioural RPIs to help
prevent relapse alongside standard cessation oriented
therapy [13,14]. This latter approach is consistent with
Marlatt and Gordon's model of relapse which predicts
that relapse may occur when ex-smokers encounter high
risk situations and employ inadequate coping responses
to avoid smoking [15]. The behavioural counselling for
relapse prevention provided would, therefore, focus on
developing smokers' coping skills prior to, or early on
within, a quit attempt.
Our findings suggest that health professionals would be
comfortable with the notion of delivering RPIs to absti-
nent smokers, but the limited evidence base for the effec-
tiveness of such interventions would need to be
strengthened before this could occur. If this were to hap-
pen and RPIs were to be used in NHS Stop Smoking Serv-
ices, interviewees believed that pharmacotherapy used as
extended treatment for relapse prevention could be easily
integrated into current routine practice, as long as costs
were addressed. However, there was little or no enthusi-
asm for the use of proactive telephone counselling to help
prevent relapse because it was considered that few absti-
nent smokers would welcome this type of contact and it
would be logistically challenging for services to under-
take.
Current performance management targets are a substan-
tial barrier to the introduction of relapse prevention sup-
port in the UK National Health Service (NHS). For
example in October 2002, the English Department of
Health (DH) stated an aim that 800,000 smokers would
successfully quit following help from smoking cessation
services by 2006 [16] and this was subsequently translated
into an aspiration that services should treat at least 5% of
their local population of smokers in the course of a year,
with an expected success range of 35% – 70% at four
weeks [17]. For these targets, success involves smokers
achieving a four week period of abstinence, so there is
considerable pressure on services to achieve a high
throughput of smokers who manage to stop smoking for
at least one month. Interviewees' comments reflected this
perceived pressure and indicated that the provision of
RPIs could not be a priority for services without a change
in the targets against which they are measured.
Interviewees were also concerned about the low uptake of
RPIs which had often led to these being withdrawn after
their introduction and was perceived as a major potential
barrier to the successful introduction of RPIs into the
NHS. Interviewees thought that relapsed smokers were
embarrassed about their 'failure' and hence did not return
for treatment. This view is consistent with the literature;BMC Health Services Research 2009, 9:67 http://www.biomedcentral.com/1472-6963/9/67
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lapsed smokers often feel guilty [18] and experience neg-
ative affect and decreased confidence in their ability to
quit [19].
Strengths and Limitations
This is, to our knowledge, the first qualitative study to
explore smoking cessation professionals' experiences of
and beliefs about providing RPIs for smokers. As inter-
viewees all worked within the UK NHS Stop Smoking
Services and as these have a strong focus on cessation
treatment, findings have highlighted relevant issues that
could hinder or facilitate the introduction of RPIs into this
environment. Our sample was small and it is possible that
by interviewing a larger, more diverse group, we would
have found other important factors relating to the use of
RPIs, however, similarities inherent in the accounts we
obtained, suggest that we have identified most of the
major issues. Also, as our sample were volunteers from
those attending a smoking cessation conference, one
might expect their views on relapse prevention interven-
tions to be better informed than those of others working
in smoking cessation.
Conclusion
Should effective RPIs be identified, it is clear that health
professionals would be positively orientated towards
delivering these via UK NHS Stop Smoking Services. How-
ever, this process would be helped by the development of
a clear definition of what relapse prevention is and should
involve and it seems very unlikely that RPIs could be suc-
cessfully introduced without current targets for perform-
ance management being altered to reward longer term
cessation. Potential RPIs should be piloted for their
acceptability to smokers making quit attempts to ensure
maximal uptake of those which are introduced and it
would be unwise to ignore the views of those working in
stop smoking services when deciding upon the logistics of
intervention delivery.
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Appendix 1
The interview schedule
1 What interventions are currently being used by your
service to help smokers who wish to stop smoking?
2 In your experience, at what point do smokers who have
quit smoking most often relapse to smoking?
3 What do you understand by smoking relapse prevention
interventions?
Experiences of delivering Relapse Prevention Interventions 
within Stop Smoking Services
4 Do you routinely provide relapse prevention interven-
tions to smokers in your service?
5 What types? (Content)
6 To whom, is it to those who have already relapsed or to
all smokers after the four week quit date, regardless of
smoking status at the time?
7 For how long is the relapse prevention intervention pro-
vided for? (Duration)
8 What percentage of smokers who relapse to smoking
take advantage of relapse prevention treatments?
(Uptake)
9 Are your staff trained to provide relapse prevention sup-
port?
10 Do you collect any data so as to monitor the effective-
ness of relapse prevention support you provide?
Feasibility
11  What do you think about the effectiveness of......?
Varenicline (champix); bupropion (zyban); extended
treatment with NRT; behavioural sessions after the four
week quit date; extended telephone contact after the four
week quit date; (This question depends on the answer to
questions 4 and 5)
Challenges Experienced
12 Is it difficult to get smokers to attend any clinics or ses-
sions after the four week quit date?
13 Are there any groups of smokers who pose a challenge
in particular?
14 What other challenges do you face with respect to pre-
venting relapse in smokers?
Service Provision
15 What is the nature and number of sessions offered?Publish with BioMed Central    and   every 
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16 What is the length and timing of these sessions?
17 What is the actual uptake of these treatment sessions
by smokers?
18 What kind of staff are involved in providing these serv-
ices for smokers who wish to quit?
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